Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Enterprise Value (2016 - 2025)

Marimed has reported Enterprise Value over the past 15 years, most recently at -$10.7 million for Q4 2025.

  • Quarterly Enterprise Value fell 18.94% to -$10.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$10.7 million through Dec 2025, down 18.94% year-over-year, with the annual reading at -$10.7 million for FY2025, 18.94% down from the prior year.
  • Enterprise Value was -$10.7 million for Q4 2025 at Marimed, down from -$8.4 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$7.9 million in Q2 2025 and troughed at -$36.3 million in Q1 2022.
  • The 5-year median for Enterprise Value is -$13.5 million (2021), against an average of -$15.9 million.
  • Year-over-year, Enterprise Value crashed 604.46% in 2021 and then soared 63.9% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$31.5 million in 2021, then soared by 63.9% to -$11.4 million in 2022, then crashed by 44.08% to -$16.4 million in 2023, then soared by 44.86% to -$9.0 million in 2024, then decreased by 18.94% to -$10.7 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Enterprise Value are -$10.7 million (Q4 2025), -$8.4 million (Q3 2025), and -$7.9 million (Q2 2025).